Cargando…
In silico evaluation of WHO-endorsed molecular methods to detect drug resistant tuberculosis
Universal drug susceptibility testing (DST) for tuberculosis is a major goal of the END TB strategy. PCR-based molecular diagnostic tests have been instrumental in increasing DST globally and several assays have now been endorsed by the World Health Organization (WHO) for use in the diagnosis of dru...
Autores principales: | Brankin, Alice, Seifert, Marva, Georghiou, Sophia B., Walker, Timothy M., Uplekar, Swapna, Suresh, Anita, Colman, Rebecca E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587982/ https://www.ncbi.nlm.nih.gov/pubmed/36273016 http://dx.doi.org/10.1038/s41598-022-21025-6 |
Ejemplares similares
-
Designing molecular diagnostics for current tuberculosis drug regimens
por: Georghiou, Sophia B., et al.
Publicado: (2023) -
Application of Targeted Next-Generation Sequencing Assay on a Portable Sequencing Platform for Culture-Free Detection of Drug-Resistant Tuberculosis from Clinical Samples
por: Cabibbe, Andrea M., et al.
Publicado: (2020) -
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis
por: Walker, Timothy M, et al.
Publicado: (2022) -
Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis
por: Georghiou, Sophia B., et al.
Publicado: (2016) -
Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation
por: Colman, Rebecca E., et al.
Publicado: (2019)